Imaging agents for the chemokine receptor 4 (CXCR4)
- 28 June 2012
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 41 (15) , 5239-5261
Abstract
The interaction between the chemokine receptor 4 (CXCR4) and stromal cell-derived factor-1 (SDF-1, also known as CXCL12) is a natural regulatory process in the human body. However, CXCR4 over-expression is also found in diseases such as cancer, where it plays a role in, among others, the metastatic spread. For this reason it is an interesting biomarker for the field of diagnostic oncology, and therefore, it is gaining increasing interest for applications in molecular imaging. Especially “small-molecule” imaging agents based on T140, FC131 and AMD3100 have been extensively studied. SDF-1, antibodies, pepducins and bioluminescence have also been used to visualize CXCR4. In this critical review reported CXCR4 targeting imaging agents are described based on their affinity, specificity and biodistribution. The level wherein CXCR4 is up-regulated in cancer patients and its relation to the different cell lines and animal models used to evaluate the efficacy of the imaging agents is also discussed (221 references).Keywords
This publication has 207 references indexed in Scilit:
- Improvement of CXCR4 tracer specificity for PET imagingJournal of Controlled Release, 2012
- Targeted non-covalent self-assembled nanoparticles based on human serum albuminBiomaterials, 2012
- Hybrid Peptide Dendrimers for Imaging of Chemokine Receptor 4 (CXCR4) ExpressionMolecular Pharmaceutics, 2011
- PET Imaging of CXCR4 Receptors in Cancer by a New Optimized LigandChemMedChem, 2011
- Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7Clinical & Experimental Metastasis, 2011
- Peptide‐Functionalized Luminescent Iridium Complexes for Lifetime Imaging of CXCR4 ExpressionChemBioChem, 2011
- The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesotheliomaThe Journal of Pathology, 2010
- The role of stromal-derived factor-1 — CXCR7 axis in development and cancerEuropean Journal of Pharmacology, 2009
- 64Cu-AMD3100—A novel imaging agent for targeting chemokine receptor CXCR4Bioorganic & Medicinal Chemistry, 2009
- Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastasesClinical & Experimental Metastasis, 2007